David Shaw’s T2 Biosystems, Inc TTOO Stock Holding History

David Shaw’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-46	Closed	-$266K	–	4347
2019 Q4	$266K	Buy	+46	New	+$435K	﹤0.01%	3688
2018 Q4	–	Sell	-24	Closed	-$897K	–	4058
2018 Q3	$897K	Sell	24 -9	-27%	-$296K	﹤0.01%	2759
2018 Q2	$1.27M	Buy	+33	New	+$1.25M	﹤0.01%	2539
2018 Q1	–	Sell	-4	Closed	-$81K	–	3843
2017 Q4	$81K	Buy	+4	New	+$82.6K	﹤0.01%	3508
2017 Q3	–	Sell	-2	Closed	-$32K	–	3655
2017 Q2	$32K	Buy	+2	New	+$40.1K	﹤0.01%	3320
2016 Q3	–	Sell	-2	Closed	-$93K	–	3605
2016 Q2	$93K	Sell	2 -3	-60%	-$135K	﹤0.01%	3258
2016 Q1	$228K	Buy	5 +2	+67%	+$88.4K	﹤0.01%	3143
2015 Q4	$140K	Hold	3	–	–	﹤0.01%	3634
2015 Q3	$144K	Sell	3 -1	-25%	-$66.4K	﹤0.01%	3565
2015 Q2	$335K	Buy	+4	New	+$347K	﹤0.01%	3371

Other funds holding TTOO

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

David Shaw's TTOO Position: Q1 2020 in Review

David Shaw sold out of T2 Biosystems, Inc (TTOO) in Q1 2020, closing a stake of 46 shares — an estimated $266K sold.

David Shaw first reported a position in TTOO in Q2 2015 and held it in 10 quarters. The position peaked at $1.27M in Q2 2018. 39 funds tracked by Wall St. Rank hold TTOO as of Q1 2020.

David Shaw reported no remaining T2 Biosystems, Inc position as of Q1 2020 after selling out during the quarter.
David Shaw sold 46 T2 Biosystems, Inc shares in Q1 2020, an estimated $266K.
David Shaw first reported a position in T2 Biosystems, Inc in Q2 2015 and held it in 10 quarters.
David Shaw's T2 Biosystems, Inc position peaked at $1.27M in Q2 2018.
39 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.